The fact that FOXQ1 and THBS2 are not expressed or expressed at very low levels in immune cells should make these two markers suitable for LN analysis, which has proved to be superior to analysis of primary tumor for prediction of outcome by molecular techniques (4, 35). The gene discussed is THBS2; the disease is neoplasm.